Home › Funds › Paradigm Biocapital Advisors LP › ORIC

Paradigm Biocapital Advisors LP position in ORIC

ORIC PHARMACEUTICALS INC · Health Care

Paradigm Biocapital Advisors LP reported holding 1,505,769 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$20.3M, representing 0.40% of its reported portfolio and ranking #22 among its reported holdings. Paradigm Biocapital Advisors LP has disclosed ORIC holdings in 3 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)1.51M sh
Reported value held$20.28M
Portfolio Weight0.40%
First reportedQ4 2025
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Paradigm Biocapital Advisors LP's ORIC position evolved

Paradigm Biocapital Advisors LP first disclosed a stake in ORIC in Q4 2025 at 2,401,217 shares (US$19.6M). The position peaked in Q1 2026 at 1,701,217 shares, worth US$21.6M. Across 3 filings, Paradigm Biocapital Advisors LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,505,769 shares valued at US$20.3M. Notable position changes include a 29% trim in Q1 2026 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 2.40M $19.64M New
Q1 2026 1.70M $21.55M Reduce
Q3 2026 1.51M $20.28M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORIC and 13F data

ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 42 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), AIHC Capital Management Ltd (US$62.4M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORIC

All ORIC fund holders →

FAQ

How long has Paradigm Biocapital Advisors LP held ORIC?

Paradigm Biocapital Advisors LP has disclosed ORIC holdings in 3 of the last 4 reported quarters, going back to Q4 2025.

What is Paradigm Biocapital Advisors LP's current position in ORIC?

As of Q3 2026, Paradigm Biocapital Advisors LP holds 1.51M shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $20.28M, representing 0.40% of its reported portfolio and ranking #22.

Has Paradigm Biocapital Advisors LP been buying or selling ORIC?

In the latest 13F filing (Q3 2026), Paradigm Biocapital Advisors LP newly opened its position in ORIC. The position peaked in Q1 2026 at 1.70M shares.

Which other funds hold ORIC?

Other major institutional holders of ORIC include Nextech Invest Ltd., AIHC Capital Management Ltd, SR ONE CAPITAL MANAGEMENT, LP, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.